Second, NK cells from LC patients may have higher sensitivity to TGF-β than those NK cells from CHB and HC subjects because anti-TGF-β treatment had more potentials to restore NK cell function in LC patients than that of HC and CHB individuals. Here, TGFB1 is linked to laryngotracheoesophageal cleft.